- $2.60m
- $13.95m
- $40.61m
- 33
- 88
- 54
- 60
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 62.6 | 53.4 | 47.8 | 44.3 | 40.6 |
Cost of Revenue | |||||
Gross Profit | 19.2 | 15.1 | 12.9 | 10.7 | 10.2 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 63.4 | 56.4 | 48 | 49.1 | 45.5 |
Operating Profit | -0.796 | -2.99 | -0.242 | -4.76 | -4.85 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.916 | -3.44 | 1.99 | -3.99 | -4.97 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.922 | -3.43 | 2 | -3.99 | -4.97 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.922 | -3.43 | 2 | -3.99 | -4.97 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -1.72 | -4.32 | 1.21 | -4.73 | -5.66 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.04 | -2.1 | -0.348 | -1.32 | -1.46 |